Today's Healthcare Pulse
Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform
Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The collaboration aims to broaden Abridge’s AI‑scribe services across more health systems and integrate with payers. The company already supports over 300 health systems.
Also developing:
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
Isomorphic Labs, the DeepMind spinoff behind AlphaFold, announced that its AI‑designed drug candidates will soon enter human clinical trials. The company’s new IsoDDE engine claims to double the accuracy of AlphaFold 3 in predicting protein‑small‑molecule interactions. Partnerships with Eli Lilly and Novartis focus the pipeline on oncology and immunology, while a $600 million funding round underwrites trial preparation. The move marks the first time DeepMind’s Nobel‑winning protein‑prediction technology is being tested as a therapeutic platform.
BROKE: Mills Quietly Freezes MaineCare Provider Payments Until July 1 as Fraud Probes Close In
Governor Janet Mills’ Department of Health and Human Services has again frozen MaineCare provider payments, postponing pharmacy claims from mid‑May through June 30 until the start of the new fiscal year on July 1. The delay follows a supplemental budget that...
Brooks-TLC Workers Ratify Contract Extension
Members of 1199SEIU United Healthcare Workers East at Brooks‑TLC Hospital System ratified a one‑year contract extension covering more than 160 employees. The agreement, effective until April 30, 2027, delivers a 3.75% wage increase and targeted hourly bumps for surgical technicians,...
Vanderbilt Chief Heads to Dana-Farber
Vanderbilt Health’s system surgeon‑in‑chief Seth Karp will leave on Oct. 15 to become surgeon‑in‑chief at Boston’s Dana‑Farber Cancer Institute. He will simultaneously chair the Department of Surgery at Beth Israel Deaconess Medical Center. The move coincides with Dana‑Farber’s $1.68 billion partnership with...
Washington Hospital Restructures Clinic, Ends Pain Management Services
East Adams Rural Healthcare (EARH) in Ritzville, Washington, is resetting its rural health clinic after a near‑closure caused by financial strain. The new model, effective June 1, will staff the clinic with a single provider on‑site each day, supported by a...
The Quiet Gaps in ED Performance Data — and What Execs Can Do About Them
Hospital leaders now have unprecedented access to emergency department (ED) data, but without adjusting for patient acuity and using appropriate peer groups, the information can be misleading. The CDC’s federal ED utilization report ended in 2022, leaving a fragmented landscape...
Birthday Cards Are Just the Start: Inside AdventHealth’s Hospitality Strategy
AdventHealth launched its Health Parks—a 36,000‑square‑foot, one‑stop‑shop model that bundles lab, imaging, primary care and specialty services under a single roof. The integrated layout lets 1‑2 of every 3 patients receive multiple services in one visit, reducing the need for...
Designer Baby Companies Are in Turmoil
Two high‑profile germline‑editing startups—Bootstrap Bio and Manhattan Genomics—have ceased operations within a year of launching. Bootstrap Bio folded after running out of capital and was further tarnished by the federal arrest of its chief science officer on child‑sex‑trafficking charges. Manhattan...
No Benefit, Maybe Harm, With Invasive Approach in Frail NSTEMI Patients
Analysis of the SENIOR‑RITA trial’s frailty sub‑study shows that severely frail NSTEMI patients do not benefit from routine invasive angiography and revascularization. Over a median 4.1‑year follow‑up, the composite of cardiovascular death or non‑fatal MI occurred in 37.7% of frail...
Friday Subscriber Discussion - Action!
The Friday Subscriber Discussion post invites readers to brainstorm actionable steps for reducing institutional weight stigma. It highlights everyday barriers, such as non‑armless chairs in waiting rooms, and encourages community members to share practical suggestions. The author frames the conversation...
Building a Better Delivery System for Gene Editing Machines by Re-Engineering the Cellular Factory
A genome‑wide knockout screen conducted by the Whitehead Institute revealed specific producer‑cell genes that govern the assembly and potency of virus‑like particles (VLPs) used for gene‑editing delivery. Disabling a single brake gene dramatically increased guide‑RNA loading, boosting particle potency across...
Biopharma Money Raised: Jan. 1-April 23, 2026
Regeneron’s Otarmeni, a gene‑therapy for congenital hearing loss, earned FDA accelerated approval and will be provided free of charge, marking a rare zero‑cost gene‑therapy launch. At AACR 2026, researchers highlighted breakthroughs in minimal residual disease (MRD) detection that sharpen relapse...
Many High-Risk Pregnant Patients Still Miss Out on Guideline-Recommended Care
New research from the Mass General Brigham system reveals that only about a quarter of high‑risk pregnant patients receive the guideline‑recommended low‑dose aspirin to prevent preeclampsia. The study, covering more than 60,000 pregnancies from 2013 to 2023, shows aspirin use...
Residency Fill Rates Worsen for Primary Care: 20 Stats to Know
The Trilliant Health report shows primary‑care residency fill rates falling despite a surge in medical‑school applications and residency slots. In the 2026 match, family medicine was 16.4% unfilled, pediatrics 5.6% and internal medicine 4.6%, with the overall primary‑care fill rate...
ChatGPT for Clinicians: The Trap Sprung
OpenAI unveiled ChatGPT for Clinicians, a free GPT‑5.4‑powered assistant for verified U.S. physicians, nurse practitioners, physician assistants and pharmacists. The tool offers peer‑reviewed literature search, reusable workflow templates such as referral letters and prior authorizations, deep journal research, and built‑in...
The Specialty Facing a Million Dollar Gender Pay Gap
A Yale‑led study of the AAMC Faculty Salary Survey (2016‑2024) shows that female ophthalmologists in academia earn less than male peers at every rank. Women now represent a slight majority of assistant professors but only 30% of full professors and...
Edwards Raises 2026 Forecast as TAVR Sales Surge
Edwards Lifesciences raised its full‑year 2026 sales‑growth outlook to 9‑11% after reporting a 16.7% jump in first‑quarter revenue to $1.65 billion, driven by a 14.4% increase in TAVR sales to $1.2 billion. The company also lifted its TAVR growth forecast to 7‑9%...
Meal Sequence Study Shows Glucose Control Comparable to Drugs
Researchers published in Diabetes Care report that simply changing the order of foods—vegetables and protein first, carbs last—lowers post‑meal blood glucose peaks by more than 40% and reduces overall glucose exposure by 38.8%, effects comparable to some glucose‑lowering drugs. The...
Social Security Announces 2.8% COLA, Yet Retirees Still Feel Inflation Pinch
Social Security revealed a 2.8% cost‑of‑living adjustment for 2026, boosting monthly checks but leaving many retirees short after Medicare Part B premium hikes and a 20% erosion of purchasing power since 2010.
Postmarketing Requirements and Commitments: Reports
The FDA publishes annual reports in the Federal Register detailing the status of post‑marketing requirements (PMRs) and commitments (PMCs) for drugs and biologics, covering both CDER and CBER. These reports summarize data from internal databases and are updated quarterly on...
Trump's Executive Order Fast‑Tracks Psychedelic Therapy Review, Boosting Compass Pathways
President Donald Trump signed an executive order this weekend to shorten clinical‑trial and regulatory timelines for psychedelic medicines. The move shines a spotlight on Compass Pathways, whose late‑stage psilocybin candidate COMP360 is poised for an FDA filing and has $149.6 million...
TRT Gel/Injection Shows More Adverse Events Than Clomiphene
Interesting retrospective chart-based study in VA population - TRT gel/injection vs. clomiphene for hypogonadism. Matched populations at baseline. Far higher rates of AEs with gel/injection vs. clomiphene. "TRT was associated with an increased incidence of mortality, CVA, CAD, hypertension,...
Researchers Launch APOLLO, a 25‑Billion‑Event AI Model to Forecast Disease
Scientists at Mass General Brigham introduced APOLLO, a transformer‑based foundation model trained on 25.2 billion medical events from 7.2 million patients. The system outperformed existing tools on 322 clinical tasks, including a 0.92 AUROC for schizophrenia onset, signaling a new era for...
Michigan Senate Bills to Force Private Insurers to Cover Infertility Treatments
Michigan Senate Majority Leader Stephanie Chang introduced SB 922, mandating private health insurers to cover fertility diagnostics, IVF, egg preservation and embryo transfer. The bill, referred to the Senate Finance, Insurance and Consumer Protection Committee, could reshape coverage mandates and...
Glutamine Transport Boost Enhances CAR‑Macrophage Cancer Therapy in Mice
A Sun Yat‑sen University team engineered CAR‑macrophages to overexpress the glutamine transporter SLC38A2, dramatically improving phagocytosis and cytokine release against HER2‑positive breast cancer cells. In mouse models, the modified cells suppressed tumor growth far more than standard CAR‑macrophages, highlighting metabolic...
WHO Prequalifies First-Ever Malaria Treatment for Newborns and Infants, Adds New Diagnostic Tests
The World Health Organization has prequalified the first antimalarial drug formulated specifically for newborns and infants weighing 2‑5 kg—artemether‑lumefantrine—enabling public‑sector procurement for an estimated 30 million babies born each year in malaria‑endemic Africa. The agency also prequalified three rapid diagnostic tests that...
Secretary Kennedy’s Eight Major Health Policy Wins to Date
HHS Secretary Ryan Kennedy has highlighted eight major health policy achievements since his February confirmation, ranging from drug‑price reductions to new dietary guidelines. The Trump RX website now lets consumers purchase prescription drugs directly from manufacturers at lower costs, while the 2024...
Pressure Points: Aristeia on Its New Battlefield Tourniquet
Aristeia introduced its Generation 8 battlefield tourniquet, aimed at military, parapublic and civilian agencies. The new device features a slimmer polymer‑composite band, a single‑hand pull‑to‑apply mechanism and visual placement cues, delivering about a 30 % faster application than the previous model. Independent...
Creative Biolabs Unveils LNP Conjugation Platform to Accelerate Precision Gene Therapy
Creative Biolabs announced the commercial release of an enhanced lipid‑nanoparticle (LNP) conjugation platform that improves payload stability and tissue targeting for gene‑editing and RNA therapeutics. The platform integrates microfluidic manufacturing and programmable ligand attachment, promising faster preclinical timelines for biotech...
AAN 2026: Tavapadon Post-Hoc Analysis Strengthens Its D1/D5 Agonist Pitch
At the 2026 American Academy of Neurology meeting, AbbVie unveiled post‑hoc results from its Phase III TEMPO‑1 and TEMPO‑2 trials of tavapadon, a once‑daily oral D1/D5 partial agonist for early Parkinson’s disease. The analysis showed statistically significant improvements in seven of...
Photo of the Week: Airway Trauma Training
EMS1 staff, a team of seasoned writers, editors, and emergency medical professionals, deliver timely, actionable content for pre‑hospital care providers. The outlet emphasizes breaking news, expert advice, and practical tools to improve EMT and paramedic performance. It promotes free subscription...
Reprogrammed Cardiomyocytes Soften the Blow in Heart Attack
A recent study published in the Journal of Molecular and Cellular Cardiology demonstrates that partial reprogramming of mouse cardiomyocytes with three Yamanaka factors (OCT4, SOX2, KLF4 – OSK) enables the cells to complete cytokinesis after a heart attack. By dismantling...
Expert Tips for Treating and Preventing ITBS
PT/coach Duane Scotti is on the pod to chat about ITBS treatment & prevention. Watch: https://youtu.be/UKJEv4cIV1g
FDA Clears Single‑Trial Path for Cambium Bio’s Elate Ocular Gene Therapy
The U.S. Food and Drug Administration granted Cambium Bio a single‑trial approval route for its Elate Ocular gene therapy, allowing the CAMOMILE‑3 Phase 3 study to serve as the sole pivotal trial. The decision reduces clinical risk, accelerates market entry and...
5 Patterns Behind Health Care Startups that Fail
Health‑care startups often fail not because of weak technology but due to strategic missteps. Dr. Harsha Moole identifies five recurring patterns: solving conference‑level problems instead of bedside needs, building products without knowing the true buyer, mistaking FDA clearance for market...
AAN 2026: Head-to-Head Trial Shows Superiority of Qulipta for Migraine Prevention
AbbVie presented Phase IIIb TEMPLE trial data at AAN 2026, showing its oral gepant Qulipta outperforms topiramate in migraine prevention. Over 24 weeks, Qulipta had a 12.1% discontinuation rate versus 29.6% for topiramate and achieved a 73.7% responder rate (>50% reduction in...
JLL Launches Healthcare Facility Accreditation Program
JLL’s healthcare division unveiled the Accreditation Lifecycle Program (ALG), a multi‑year compliance solution designed to keep hospitals continuously ready for The Joint Commission’s new Accreditation 360 standards. The platform aligns with the Joint Commission’s cycle, centralizing drawings, inspections and audit trails...
Sanofi MS Drug Rejected in US Gets an Endorsement in Europe
Sanofi’s experimental multiple‑sclerosis drug tolebrutinib, marketed as Cenrifki, received a positive recommendation from the European Medicines Agency for secondary progressive MS, after the U.S. FDA rejected it earlier this year. The EMA’s endorsement paves the way for a final approval...
HIMSSCast: Medicaid as a Health IT Innovation Engine
Dr. Christopher R. Cogle argues that Medicaid, covering over 80 million Americans, functions as a powerful health‑IT innovation engine. Designing systems for the most complex, vulnerable populations has spurred advances in data infrastructure, managed‑care oversight, and population‑health analytics. The HIMSSCast episode...
AI May Be Approaching a New Phase in Healthcare, on Two Fronts
Physicians are adopting Anthropic's agentic AI tool Claude Code to build custom clinical applications, signaling a shift toward doctor‑led software development within health systems. The latest frontier model, Claude Mythos, can identify code vulnerabilities, prompting security leaders to warn of...
LogiPharma Europe: A New Model for Cold Chain Decision-Making
At LogiPharma Europe 2026, Roche’s global head of Distribution Technology, Raquel Vazquez, outlined a shift from experience‑based to data‑driven cold‑chain decision‑making. She highlighted the need to contextualize fragmented sensor data across lanes, products and environmental conditions to select the right packaging...
Official Statistics: Mefloquine (Larium) Prescribing in the UK Armed Forces: 12 September 2016 to 31 March 2026
The UK Ministry of Defence has published official statistics on mefloquine (Larium) prescribing within the armed forces from September 2016 through March 2026, following a policy shift introduced in 2016. The data reveal a steady decline in mefloquine use, increased...
Most Pediatric Flu Deaths Occur in Unvaccinated Kids
#Flu season is over, but pediatric flu deaths continue to be reported. In the week ending 4/18, 6 more deaths were reported to #CDC. They bring the season's total so far to 149 deaths in kids; more such reports may...
Eugene Braunwald: Repeatedly Revolutionizing Cardiology
On the passing of Dr. Braunwald... 🩺How Dr. Eugene Braunwald changed cardiology, again and again and again. https://t.co/IaAIMy3X3N #medicine #cardiology @harvardmed @CMichaelGibson
Health Plans Adopt Standardized Approach to Prior Authorization
Health plans, including UnitedHealthcare, Cigna, Aetna, Humana and major Blue Cross entities, announced a voluntary initiative to use a standardized electronic prior‑authorization (e‑PA) format beginning Jan. 1, 2027. The new standard will cover common services such as orthopedic surgery, CT scans and...
Top Strategies Driving Success in Healthcare Search
What’s actually working in healthcare search right now? We break it down with Lacey Reichwald. 👉 Hear the full interview: https://t.co/ySBa6IYcvJ @ahamediagroup #marketingstrategy #hcmktg
Novo Nordisk's Breakthrough Launch at Attractive 11x PE
Watch the launch of the holy grail of pharma. Beautiful And still at a PE of ~11x. $NVO
How Northwell Health Engages Specialists in Value-Based Care
Northwell Health, overseeing 29 hospitals and 800+ ambulatory sites, is tackling the specialist‑centric gap in value‑based care. While most ACO contracts focus on primary‑care metrics, specialists account for the bulk of utilization costs and patient complexity. To bridge this, Northwell...
Lilly Slides as FDA Plans Psychedelic Voucher Program
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics https://t.co/kWvYtFeif0 $LLY - 4% $NVO + 6% $REGN $AMGN $BBOT #biotech
Health System Failure: A Personal Apology
our health system is SO broken. So sorry you had to experience this so directly...